Compare Baroda BNP Paribas Health and Wellness Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.33
1.93
NAV
₹9.37
₹430.58
Fund Started
09 Jun 2025
04 Jun 1999
Fund Size
₹515.19 Cr
₹4063.64 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
4.19%
3 Year
-
24.41%
5 Year
-
15.77%
Equity
95.92%
98.16%
Cash
-0.44%
1.77%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.23% |
Lupin Ltd. | 6.29% |
Abbott India Ltd. | 5.53% |
Torrent Pharmaceuticals Ltd. | 5.32% |
Ipca Laboratories Ltd. | 5.28% |
Laurus Labs Ltd. | 4.43% |
JB Chemicals & Pharmaceuticals Ltd. | 4.41% |
Astrazeneca Pharma India Ltd. | 3.92% |
SBI Life Insurance Company Ltd. | 3.45% |
Emcure Pharmaceuticals Ltd. | 3.36% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 6.59% |
Acutaas Chemicals Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.48% |
Max Healthcare Institute Ltd. | 4.97% |
Lupin Ltd. | 4.10% |
Aster DM Healthcare Ltd. | 3.96% |
Torrent Pharmaceuticals Ltd. | 3.74% |
Aether Industries Ltd. | 3.56% |
Biocon Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
09 Jun 2025
04 Jun 1999
